A group of major American hospitals established a nonprofit generic drug company, Civica Rx, to battle long-lasting shortages of critical medicines and their high prices. Their goals are providing stable supplies for 14 generic drugs used in hospitals and price transparency. This will allow hospitals to save time and money while providing patients with better health care.
Researchers from The University of Toledo have found the chemical reason behind why blue light damages our eyes over time, contributes to macular degeneration, and can even cause blindness. Since we’re spending more time in front of screens than ever before, this finding might be a big step forward toward preventing eyesight deterioration.
Researchers from the University of Tennessee Institute of Agriculture presented a concept of houseplants as aesthetically pleasing and functional alarm systems of home health. They have effectively connected two seemingly unrelated disciplines – plant sciences and architectural design. Genetically engineered houseplants could detect viruses, such as influenza virus, odors, and other volatile organic compounds that plants can “inhale” through their leaves.
Zebrafish have become the animal model of choice for research in many areas. Now, researchers from Rice University trace roots of cancer development using genetically modified zebrafish. These fish produce fluorescent tags in migratory embryonic nerve precursor cells, enabling them to trace neuroblastoma and other forms of cancer.
Researchers from Arizona State University and the Icahn School of Medicine at Mount Sinai Indiana University made a large-scale analysis and used data from three different brain banks. They concluded that human herpes viruses are more abundant in the brains of Alzheimer’s patients and may play a role in regulatory genetic networks believed to be behind the onset of the disease. New possibilities for Alzheimer’s treatment, such as antiviral and immune therapy, are now open.
Men are still limited to only a few forms of birth control. Scientists are making constant progress but the birth control pill or any other hormonal contraceptives for men are still years away from being safe, reversible, and broadly available. In the past, low demand and focus on women contraceptives partly limited development. Now, more and more men want to take control over their own fertility.
Researchers from Indiana University (IU) have made the first direct visual observation of bacteria taking up foreign DNA from its surrounding. It is a key step in their process of rapidly evolving new traits, including troublesome drug resistance. The new methods developed by the researchers provided them with the ability to catch this mechanism on film.
Researchers from the University of California have programmed synthetic cells to mobilize nearby natural cells into complex structures. At first, individual cells self-organized into multi-layered structures resembling simple organisms or the tissues from the first stages of embryonic development. The technology could have a bright future in repairing damaged tissue or re-growing injured organs.
Engineers from the University of Illinois built a 3D printer that produces a delicate network of thin ribbons of hardened sugar alcohol, isomalt. These detailed biological structures are water-soluble, biodegradable glassy structures that could have multiple applications in biomedical engineering, cancer research, and device manufacturing.
Rather than relying on serendipity to discover novel therapeutics, today we can work intelligently to identify antibodies that target exactly what we desire. Our immune system has been refined through millions of years of evolution, and our ability to harvest its capabilities now allows us to develop intelligently designed antibody-based medicines. This new generation of biotherapeutics holds great promise in tackling diseases and conditions that were previously untreatable.